These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19349312)

  • 21. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone agonist in premenopausal women does not alter hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone.
    Gavin KM; Shea KL; Gibbons E; Wolfe P; Schwartz RS; Wierman ME; Kohrt WM
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E316-E325. PubMed ID: 29631362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in cardiovascular and corticoadrenal response to stress and drug cues in cocaine dependent individuals.
    Fox HC; Garcia M; Kemp K; Milivojevic V; Kreek MJ; Sinha R
    Psychopharmacology (Berl); 2006 Apr; 185(3):348-57. PubMed ID: 16514523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the hypothalamic-pituitary-adrenal axis in reinstatement of cocaine-seeking behavior in squirrel monkeys.
    Lee B; Tiefenbacher S; Platt DM; Spealman RD
    Psychopharmacology (Berl); 2003 Jul; 168(1-2):177-183. PubMed ID: 12652344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The corticotropin-releasing hormone stimulation test in chronic schizophrenia.
    Roy A; Pickar D; Doran A; Wolkowitz O; Gallucci W; Chrousos G; Gold P
    Am J Psychiatry; 1986 Nov; 143(11):1393-7. PubMed ID: 3022612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sex and early maternal abuse on adrenocorticotropin hormone and cortisol responses to the corticotropin-releasing hormone challenge during the first 3 years of life in group-living rhesus monkeys.
    Sanchez MM; McCormack K; Grand AP; Fulks R; Graff A; Maestripieri D
    Dev Psychopathol; 2010; 22(1):45-53. PubMed ID: 20102646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-related differences in stimulated hypothalamic-pituitary-adrenal axis during induced gonadal suppression.
    Roca CA; Schmidt PJ; Deuster PA; Danaceau MA; Altemus M; Putnam K; Chrousos GP; Nieman LK; Rubinow DR
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4224-31. PubMed ID: 15886244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans.
    Baram TZ; Mitchell WG; Haden E
    Mol Psychiatry; 1996 Sep; 1(4):320-4. PubMed ID: 9118358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
    Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.
    Curtis GC; Abelson JL; Gold PW
    Biol Psychiatry; 1997 Jan; 41(1):76-85. PubMed ID: 8988798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
    Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
    Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal and environmental factors influence the hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone infusion in offspring of mothers with or without mood disorders.
    Ronsaville DS; Municchi G; Laney C; Cizza G; Meyer SE; Haim A; Radke-Yarrow M; Chrousos G; Gold PW; Martinez PE
    Dev Psychopathol; 2006; 18(1):173-94. PubMed ID: 16478558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.
    Rybakowski JK; Twardowska K
    J Psychiatr Res; 1999; 33(5):363-70. PubMed ID: 10504004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
    Wirtz PH; Siegrist J; Schuhmacher A; Hoefels S; Maier W; Zobel AW
    Psychoneuroendocrinology; 2010 May; 35(4):536-43. PubMed ID: 19818562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques.
    Barr CS; Dvoskin RL; Yuan Q; Lipsky RH; Gupte M; Hu X; Zhou Z; Schwandt ML; Lindell SG; McKee M; Becker ML; Kling MA; Gold PW; Higley D; Heilig M; Suomi SJ; Goldman D
    Arch Gen Psychiatry; 2008 Aug; 65(8):934-44. PubMed ID: 18678798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of corticotropin-releasing hormone testing in assessment of hypothalamic-pituitary-adrenal axis function in infants with congenital central hypothyroidism.
    van Tijn DA; de Vijlder JJ; Vulsma T
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3794-803. PubMed ID: 18647808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.